Back
Karyopharm Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
KPTI
Karyopharm Therapeutics, Inc.
Last Price:
$9.70
Seasonality Move:
-13.4%
7 Day Trial
ALL ACCESS PASS
$
7
Karyopharm Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 13% based on the past 12 years of stock performance.
-
Karyopharm Therapeutics, Inc. has fallen lower in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Karyopharm Therapeutics, Inc. Stock Undervalued?The current Karyopharm Therapeutics, Inc. [KPTI] share price is $9.25. The Score for KPTI is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
KPTI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 13% based on the past 12 years of stock performance.
Karyopharm Therapeutics, Inc. Stock Rating
Buy
73
Karyopharm Therapeutics, Inc. (KPTI)
is a Buy
Is Karyopharm Therapeutics, Inc. overpriced?
-
Karyopharm Therapeutics, Inc. has fallen lower in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Karyopharm Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
10.38
52-Week Low:
3.51
Prediction Charts
Market Cap:
169.7M
Price in USD:
9.25
Volume:
754.7K
Beta:
0.81
Technical Analysis
SMA50:
7.05
SMA100:
6.48
SMA200:
5.81
52-Wk Change:
-2.12%
Stock Predictions
-
Is Karyopharm Therapeutics, Inc. stock public?Yes, Karyopharm Therapeutics, Inc. is a publicly traded company.
-
What is the Karyopharm Therapeutics, Inc. stock quote today?The Karyopharm Therapeutics, Inc. stock price is 9.25 USD today.
-
How to buy Karyopharm Therapeutics, Inc. stock online?You can buy Karyopharm Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-29 | 6.95 | 6.63 | 7.08 | 6.61 |
| Jan-30 | 6.66 | 6.52 | 6.80 | 6.42 |
| Feb-2 | 6.52 | 6.31 | 6.68 | 6.22 |
| Feb-3 | 6.33 | 6.55 | 6.88 | 6.25 |
| Feb-4 | 6.56 | 6.30 | 6.70 | 6.06 |
| Feb-5 | 6.43 | 6.09 | 6.97 | 6.02 |
| Feb-6 | 6.22 | 6.26 | 6.66 | 6.00 |
| Feb-9 | 6.30 | 6.31 | 6.60 | 5.90 |
| Feb-10 | 6.28 | 6.59 | 6.70 | 6.20 |
| Feb-11 | 6.58 | 7.37 | 7.38 | 6.28 |
| Feb-12 | 6.72 | 8.94 | 9.94 | 6.72 |
| Feb-13 | 8.98 | 8.58 | 9.45 | 8.11 |
| Feb-17 | 8.63 | 9.40 | 9.94 | 8.42 |
| Feb-18 | 9.64 | 9.25 | 9.82 | 9.14 |
Karyopharm Therapeutics, Inc. Earnings
Karyopharm Therapeutics, Inc. Earnings Report: Per Share Karyopharm Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Karyopharm Therapeutics, Inc. Forecast Revenue Growth
Karyopharm Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Karyopharm Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.72 per share, and an increase next year of $0.92 per share.
* Karyopharm Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.